dBio has joined the American Heart Association (AHA) Centre for Health Technology & Innovation Innovators' Network, a programme aimed at fostering partnerships to develop scalable and innovative healthcare solutions.

The Centre focuses on advancing efficient and impactful healthcare technologies, bringing together experts and organisations to accelerate innovation that improves cardiovascular health and patient care globally.

Through its membership in the Innovators' Network, dBio will gain access to the AHA's digital library of scientific guidelines and clinical recommendations. This resource supports the development of evidence-based digital healthcare technologies.

Members also benefit from collaborative opportunities such as creating clinical outcome models, which reduce the cost and complexity of conducting independent studies. These collaborations aim to demonstrate how digital platforms can improve healthcare outcomes, addressing critical concerns for healthcare providers and payers.

This partnership aligns with dBio's goals of enhancing cardiovascular care through technology. The company plans to leverage the AHA's expertise to advance StethoCloud, its AI-powered wearable stethoscope. This innovative device delivers real-time insights to healthcare professionals and individuals at home, promoting better care decisions and improved health outcomes.

Participation in the Innovators' Network reinforces dBio's commitment to advancing global cardiovascular health. By contributing to the Centre's ecosystem, the company aims to accelerate the adoption of transformative healthcare solutions, supporting the AHA's mission to improve the well-being of individuals and communities worldwide.




Source: prnewswire.com

Report Abuse